|
Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study |
|
|
|
Titel: |
Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study |
Auteur: |
Amorim, Sandy Stathis, Anastasios Gleeson, Mary Iyengar, Sunil Magarotto, Valeria Leleu, Xavier Morschhauser, Franck Karlin, Lionel Broussais, Florence Rezai, Keyvan Herait, Patrice Kahatt, Carmen Lokiec, François Salles, Gilles Facon, Thierry Palumbo, Antonio Cunningham, David Zucca, Emanuele Thieblemont, Catherine |
Verschenen in: |
The Lancet. Haematology |
Paginering: |
Jaargang 3 (2016) nr. 4 pagina's nvt p. |
Jaar: |
2016 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|